Cardurion last raised $260.0M in its Later Stage VC (Series B) (Jul 2024).
- ·The complete investor list: 16 names
- ·Watch Cardurion: the Monday email on marks, rounds and moves
Cardurion funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Later Stage VC (Series B) | $260.0M | ▮ | ▮ |
Membership and data by Private Market View
Cardurion valuation
Cardurion's last known valuation is $760 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Cardurion raised?
Cardurion has raised $622 million in total; 1 of its rounds is on record. The largest on record was a $260 million Series B in Jul 2024.
Comparable companies
Comparable biotechnology names by valuation on PrivateMarketView: DNA Script ($660 million), Odyssey Therapeutics ($638 million) and bit.bio ($546 million).
How Cardurion's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Cardurion, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Cardurion
- What is Cardurion worth?
- Cardurion's last known valuation is $760.0M.
- How much has Cardurion raised?
- Cardurion has raised $621.8M in total funding across 1 recorded rounds.
- When did Cardurion last raise?
- Cardurion last raised in Jul 2024 (Later Stage VC (Series B)), raising $260.0M.